Isabela Cristina Ferreira Barbosa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Isabela Cristina Ferreira Barbosa has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Charise Dallazem Bertol
Universidade de Passo Fundo, Brazil
2 shared publications - Vitória Citolin Crestani
University of Passo Fundo. Passo Fundo; Brasil
2 shared publications - Ana Luisa Sant’aNna Alves
Universidade de Passo Fundo, Brazil
1 shared publication - Nathalia de Souza Rodrigues
Curso de Farmácia , Universidade de Passo Fundo , Passo Fundo , Rio Grande do Sul, Brazil , upf.br
1 shared publication - Tatiana Staudt
Universidade de Passo Fundo, Brazil
1 shared publication
Latest Publications
- Open Access
- 19 November 2025
- Published by Universidad Nacional de Misiones in Revista de Ciencia y Tecnología
- Vol. 44 (1) , 76-84
In vitro evaluations of warfarin tablets available in the brazilian market
The aging of the population has led to an increased use of anticoagulants such as sodium warfarin. This study evaluated the quality of 5 mg warfarin tablets by analyzing eight samples (A1–A8) in accordance with the Brazilian Pharmacopoeia, with the objective of identifying quality deviations and verifying their interchangeability with the referencemedication.The samples were subjected to the following quality control tests: average weight, friability (loss <1.5%), disintegration (within 30 minutes), dosing(content between 92.5% and 107.5%), and content uniformity (acceptance value <15). However, sample A3 failed the dissolution test, releasing less than 40% of the active ingredient within 30 minutes.The equivalence assessment indicated that samplesA1xA2 (69.97) and A1xA4 (54.43) were interchangeable, whereas samples A3, A5, A6, A7, and A8 were not.The comparison of dissolution profiles using the similarity factor (f₂) revealed that several samples exhibited quality deviations, potentially compromising treatment efficacy and safety, and suggesting deficiencies in Good Manufacturing Practices (GMP).
- 19 November 2025
- Published by Universidad Nacional de Misiones in Revista de Ciencia y Tecnología
- Vol. 44 (1) , 76-84
Open AccessIn vitro evaluations of warfarin tablets available in the brazilian market
The aging of the population has led to an increased use of anticoagulants such as sodium warfarin. This study evaluated the quality of 5 mg warfarin tablets by analyzing eight samples (A1–A8) in accordance with the Brazilian Pharmacopoeia, with the objective of identifying quality deviations and verifying their interchangeability with the referencemedication.The samples were subjected to the following quality control tests: average weight, friability (loss <1.5%), disintegration (within 30 minutes), dosing(content between 92.5% and 107.5%), and content uniformity (acceptance value <15). However, sample A3 failed the dissolution test, releasing less than 40% of the active ingredient within 30 minutes.The equivalence assessment indicated that samplesA1xA2 (69.97) and A1xA4 (54.43) were interchangeable, whereas samples A3, A5, A6, A7, and A8 were not.The comparison of dissolution profiles using the similarity factor (f₂) revealed that several samples exhibited quality deviations, potentially compromising treatment efficacy and safety, and suggesting deficiencies in Good Manufacturing Practices (GMP).
- 1 January 2025
- Published by UPF Editora
- p. 62-68
Uso de anticoagulantes em idosos e suas implicações